234 related articles for article (PubMed ID: 1102977)
1. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
[No Abstract] [Full Text] [Related]
2. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Harker LA; Hirsh J; Gent M; Genton E
Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
[No Abstract] [Full Text] [Related]
3. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
4. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
5. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
[No Abstract] [Full Text] [Related]
6. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
7. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
8. [Treatment with antiplatelet drugs. Current status of knowledge].
Dettori AG; Pini M; Quintavalla R
Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
[No Abstract] [Full Text] [Related]
9. Treating thromboembolic disease.
Deykin D; Gurewich V; Harker L; Hirsch J
Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
[No Abstract] [Full Text] [Related]
10. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
11. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy: antiplatelet therapy (second of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
14. Platelet suppressive therapy.
Turpie AG; Hirsh J
Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
[No Abstract] [Full Text] [Related]
15. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Friedman LM
Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
[TBL] [Abstract][Full Text] [Related]
16. Use of common antiplatelet drugs for vascular diseases.
Pagano T; Nair CK; Sketch MH
Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
[No Abstract] [Full Text] [Related]
17. Antiplatelet agents: a review.
Gantmacher ML
J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
[No Abstract] [Full Text] [Related]
18. Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
Robertson JT; Dugdale M; Salky N; Robinson H
Thromb Diath Haemorrh; 1975 Nov; 34(2):598. PubMed ID: 1105880
[No Abstract] [Full Text] [Related]
19. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
20. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
[Next] [New Search]